News
RDTCF
0.090
NaN%
--
Rapid Dose Therapeutics upgrades Burlington facility to expand pharmaceutical manufacturing capacity
PUBT · 04/14 10:11
Rapid Dose Therapeutics Upgrades Burlington Plant for Global Pharma and Cannabis Growth
TipRanks · 04/13 14:10
Rapid Dose begins Burlington facility upgrades to expand pharmaceutical manufacturing capacity
PUBT · 04/13 13:51
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
Newsfile · 04/13 13:51
Rapid Dose plans quarterly debt interest payment in shares at C$0.11 each
Reuters · 04/06 20:30
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Newsfile · 04/06 20:30
Rapid Dose Therapeutics to Pay High-Interest Note Obligations in Shares
TipRanks · 04/06 14:11
Rapid Dose Therapeutics secures Indian patent IN 582202 for bilayer nicotine oral film; global IP reach grows to 158 jurisdictions
Reuters · 03/27 08:21
Rapid Dose Therapeutics Details 2026 Strategy and Global Expansion Drive
TipRanks · 03/26 14:12
Rapid Dose Therapeutics secures India patent IN 582202 for nicotine bilayer oral film; global IP portfolio grows
Reuters · 03/26 13:09
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory
Newsfile · 03/26 13:09
Rapid Dose Therapeutics Secures Indian Patent for QuickStrip Nicotine Bilayer Oral Film
Reuters · 03/05 15:08
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
Newsfile · 03/05 15:08
Rapid Dose Wins Key Indian Patent for QuickStrip Nicotine Oral Film
TipRanks · 03/05 14:21
Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
TipRanks · 02/23 14:43
Rapid Dose Therapeutics Updates QuickStrip Cannabinoid Research and CBD Bioavailability Study Progress
Reuters · 02/23 14:19
Rapid Dose Therapeutics advances CBD QuickStrip clinical bioavailability study
Reuters · 02/23 11:13
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
Newsfile · 02/23 11:12
Rapid Dose Therapeutics Begins Trading on OTCQB in US
Reuters · 02/12 08:03
Rapid Dose Therapeutics Lists on U.S. OTCQB to Broaden Investor Access
TipRanks · 02/11 17:09
More
Webull provides a variety of real-time RDTCF stock news. You can receive the latest news about Rapid Dose Thera through multiple platforms. This information may help you make smarter investment decisions.
About RDTCF
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.